• 1. Xiamen Eye Center of Xiamen University, Xiamen 361003, China;
  • 2. Department of Ophthalmology, Peking University People’s Hospital, Beijing 100044, China;
Li Xiaoxin, Email: dr_lixiaoxin@163.com
Export PDF Favorites Scan Get Citation

Retinal vein occlusion (RVO) is a closely related disease of ophthalmology and systemic diseases. The Expert consensus on clinical diagnosis and treatment path of retinal vein occlusion in China (consensus) emphasizes that etiological diagnosis and treatment should be paid primary attention to, and etiological exploration should be placed in an important position in the diagnosis and treatment path. In addition to etiological treatment, the consensus emphasizes that clinical attention should be paid to the management of anterior segment neovascularization, neovascular glaucoma and macular edema. Especially for patients with short course of central retinal vein occlusion, the occurrence of 100-day glaucoma should be vigilant, and active anti-vascular endothelial growth factor (VEGF) drugs, laser photocoagulation and intraocular pressure treatment should be taken. For the treatment of macular edema, the consensus points out that anti-VEGF drugs and intraocular glucocorticoid sustained-release agents are effective, but the latter should be used cautiously to avoid problems such as high intraocular pressure glaucoma and accelerated cataract formation. For deficient RVO, the consensus defines its concept, defines the time point of treatment when combined with macular edema, and clarifies the applicable conditions of laser therapy.

Citation: Li Xiaoxin. Key points interpretation of Expert consensus on clinical diagnosis and treatment path of retinal vein occlusion in China. Chinese Journal of Ocular Fundus Diseases, 2024, 40(4): 264-267. doi: 10.3760/cma.j.cn511434-20240320-00113 Copy

  • Previous Article

    National consensus on the management of major chronic fundus diseases in China: a modified Delphi approach
  • Next Article

    The changes in macular thickness at multiple locations before and after thrombolysis in patients with central retinal artery occlusion